Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer

Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer

<i>Background:</i> The objective of this study was to investigate the optimal neoadjuvant therapy (NAT) for borderline resectable pancreatic cancer invading the portal vein (BR-PV) or abutting major arteries (BR-A). <i>Methods:</i> We retrospectively analyzed 88 patients with...

Full description

Bibliographic Details
Main Authors:	Nana Kimura, Suguru Yamada, Hideki Takami, Kenta Murotani, Isaku Yoshioka, Kazuto Shibuya, Fuminori Sonohara, Yui Hoshino, Katsuhisa Hirano, Toru Watanabe, Hayato Baba, Kosuke Mori, Takeshi Miwa, Mitsuro Kanda, Masamichi Hayashi, Koshi Matsui, Tomoyuki Okumura, Yasuhiro Kodera, Tsutomu Fujii
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Cancers
Subjects:	pancreatic cancer borderline resectable neoadjuvant treatment chemoradiotherapy prognostic nutritional index
Online Access:	https://www.mdpi.com/2072-6694/13/1/36

Similar Items

Multicenter randomized phase II trial of prophylactic right‐half dissection of superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic head cancer
by: Suguru Yamada, et al.
Published: (2021-01-01)

STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
by: Melanie Spitzner, et al.
Published: (2014-09-01)

Firsthand experience of chemoradiotherapy in patients with localized small cell lung cancer. Retrospective assessment
by: A. E. Kuzminov, et al.
Published: (2020-07-01)

Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study
by: Yutaka Endo, et al.
Published: (2019-08-01)

Metachronous rupture of a residual pancreaticoduodenal aneurysm after release of the median arcuate ligament: a case report
by: Nana Kimura, et al.
Published: (2020-02-01)

Genome-wide identification and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissue
by: Yuki Sunagawa, et al.
Published: (2021-03-01)

Efficacy of modified neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A single institution experience in Taiwan
by: Yi-Ying Wu, et al.
Published: (2014-01-01)

Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
by: Q. P. Janssen, et al.
Published: (2021-03-01)

Difference between carbohydrate antigen 19‐9 and fluorine‐18 fluorodeoxyglucose positron emission tomography in evaluating the treatment efficacy of neoadjuvant treatment in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma: Results of a dual‐center study
by: Hirofumi Akita, et al.
Published: (2021-05-01)

Frequency of chemoradiotherapy-induced mucositis and related risk factors in patients with the head-and-neck cancers: A survey in the North of Iran
by: Hamid Saeidi Saedi, et al.
Published: (2019-01-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy
by: Magdalena Zaborowska-Szmit, et al.
Published: (2021-09-01)

Erythropoietins (Epostim®) during chemoradiotherapy for malignancies in anemic patients
by: V. A. Titova, et al.
Published: (2014-08-01)

THE RATE OF PATHOLOGICAL COMPLETE RESPONSE AND LONG-TERM OUTCOMES OF COMBINED TREATMENT FOR MIDDLE AND LOW RECTAL CANCER
by: S. M. Demidov, et al.
Published: (2015-02-01)

Gliomatosis cerebri: Case series of six cases with review of literature
by: Vamsi Krishna Yerramneni, et al.
Published: (2015-10-01)

Secondary ALL after Successful Treatment of Ewing's Sarcoma: A Case Report
by: Kourosh Goudarzi Pour, et al.
Published: (2016-10-01)

Rectal Lymphoma: Report of a Rare Case and Review of Literature
by: Jalall Vahedian Ardakani, et al.
Published: (2014-10-01)

The Contribution of Adding Chemoradiotherapy to Adjuvant Chemotherapy in Pancreatic Cancer Patients
by: Gökhan Uçar, et al.
Published: (2020-12-01)

Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial
by: Laura Kairevičė, et al.
Published: (2017-01-01)

Chemoradiotherapy-Associated Myelosuppression: A Retrospective Analysis of Risk Factors for Patients with Non-Small Cell Lung Cancer
by: Ufuk Mehmet Yılmaz, et al.
Published: (2015-04-01)

Comparison of Auditory Effects after IMRT with Concurrent Cisplatin for Locally Advanced Head and Neck Cancer
by: Sushil Kumar Aggarwal, et al.
Published: (2019-10-01)

Clinical prognostic factors in newly diagnosed glioblastoma
by: Ionela Bizu, et al.
Published: (2019-06-01)

An Anterior Primary Myxoid Liposarcoma Case
by: Ercan Kurtipek, et al.
Published: (2015-08-01)

Complete remission of relapsed cervical cancer through immunochemoradiotherapy: Two case reports and three proposed mechanism
by: Yi-Hao Lin, et al.
Published: (2016-08-01)

Patterns of Care and Outcome in Elderly Patients With Cervical Cancer: A Retrospective Analysis
by: Meng-Hao Wu, et al.
Published: (2011-06-01)

Preoperative chemoradiotherapy for locally advanced gastric cancer
by: Pepek Joseph M, et al.
Published: (2013-01-01)

The Effect of the Surgical Margins on the Outcome of Patients with Head and Neck Squamous Cell Carcinoma: Single Institution Experience
by: Hany Eldeeb, et al.
Published: (2012-03-01)

The Effect of the Surgical Margins on the Outcome of Patients with Head and Neck Squamous Cell Carcinoma: Single Institution Experience
by: Hany Eldeeb, et al.
Published: (2012-03-01)

Influence of Chemoradiotherapy Strategies and Factors on the Five-Years Survival of Patients with Esophageal Cancer
by: Seyed Kazem Mirinezhad, et al.
Published: (2014-08-01)

Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy
by: Yukiko Niwa, et al.
Published: (2019-01-01)

Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab
by: Kageaki Taima, et al.
Published: (2020-07-01)

Progress in Multimodal Treatment for Advanced Esophageal Squamous Cell Carcinoma: Results of Multi-Institutional Trials Conducted in Japan
by: Kazuo Koyanagi, et al.
Published: (2021-12-01)

A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol
by: Chen Li, et al.
Published: (2019-04-01)

Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma
by: Teiichi Sugiura, et al.
Published: (2020-07-01)

Current principles for the planning and performance of radiotherapy in the conservative treatment of locally advanced cancer of the cervix uteri
by: Yu. M. Kreynina, et al.
Published: (2014-07-01)

Outcomes of combination therapy for stage IIA–IIIB cervical cancer
by: D. K. Reyes Santiago, et al.
Published: (2019-02-01)

ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Role of adjuvant chemotherapy in patients with rectal cancer after preoperative chemoradiotherapy: results of a retrospective study
by: M. Yu. Fedyanin, et al.
Published: (2018-07-01)

BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Combination treatment of rectal cancer using polyradiomodification and short courses of neoadjuvant radiotherapy
by: Yu. A. Barsukov, et al.
Published: (2019-10-01)